Android app Apple app link

Nurix Therapeutics, Inc. (NRIX) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$9.38

north_east
$0.3 (3.3%)
Day's range
$8.99
Day's range
$9.49

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
10/22/2025 RBC Capital Gregory Renza $29.00 $10.63   172.81%
10/10/2025 Oppenheimer Matthew Biegler $28.00 $10.86   157.83%
07/15/2025 Morgan Stanley Terence Flynn $16.00 $12.69   26.08%
07/10/2025 Oppenheimer Matthew Biegler $30.00 $12.67   136.78%
02/03/2025 Morgan Stanley Terence Flynn $17.00 $18.95   -10.29%
12/05/2024 BMO Capital Etzer Darout $35.00 $20.06   74.48%
10/23/2024 UBS David Dai $35.00 $24.78   41.24%
10/21/2024 H.C. Wainwright Robert Burns $30.00 $25.19   19.09%
10/15/2024 Oppenheimer Matthew Biegler $35.00 $24.87   40.73%
10/15/2024 Wells Fargo Derek Archila $32.00 $25.16   27.19%
10/14/2024 Stifel Nicolaus Stephen Willey $34.00 $24.98   36.11%
10/11/2024 Jefferies Roger Song $41.00 $23.04   77.96%
09/05/2024 Robert W. Baird Brian Skorney $26.00 $24.44   6.38%
08/14/2024 Oppenheimer Matthew Biegler $27.00 $21.92   23.18%
06/27/2024 RBC Capital Gregory Renza $26.00 $20.70   25.6%
06/18/2024 H.C. Wainwright Robert Burns $26.00 $18.44   41%
06/05/2024 Piper Sandler Tyler Van Buren $35.00 $15.95   119.44%
04/11/2024 RBC Capital Gregory Renza $23.00 $15.69   46.59%
04/11/2024 Robert W. Baird Joel Beatty $25.00 $15.69   59.34%

Nurix Therapeutics, Inc. FAQ's

Nurix Therapeutics, Inc. has been rated by research analysts at Truist Financial, H.C. Wainwright, BTIG, Wells Fargo, RBC Capital, Stifel Nicolaus in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.